Utah-based Avalon Healthcare Group to acquire 10 skilled nursing centers from Springfield-based Pinnacle Healthcare

Cara Livernois | | Health Exec | Management

Avalon Healthcare Group announced plans to acquire 10 skilled nursing facilities in Oregon, including three in Eugene, reports The Register-Guard.

Avalon Healthcare Group, based in Salt Lake City, plans to enter the Oregon market by acquiring the business of Pinnacle Healthcare, a longtime Oregon-based company. 

The Oregon centers include: French Prairie Nursing and Rehabilitation Center in Woodburn; Corvallis Manor Nursing and Rehabilitation Center in Corvallis; Rose Haven Nursing Center in Roseburg; Umpqua Valley Nursing & Rehabilitation Center in Roseburg; Hearthstone Nursing & Rehabilitation Center in Medford; Royale Gardens Health & Rehabilitation Center in Grants Pass; and Highland House Nursing & Rehabilitation Center in Grants Pass.

The deal also includes the following Eugene centers: Green Valley Rehabilitation Center, on Adkins Street; Hillside Heights Rehabilitation Center, on McClean Boulevard; and South Hills Rehabilitation Center, on East 28th Avenue.

“Pinnacle is the legacy of the Hart and Garber family,” the company’s chief executive Merlin Hart said in prepared remarks. “Together, we have been a part of the health care fabric of Oregon for nearly 70 years. When we looked for an organization with a similar mission, values and vision to continue our legacy for years to come, Avalon Health Care rose to the top.”

Avalon will gain Pinnacle’s Oregon centers that have 1,108 beds, including 303 beds in Eugene. The 1,324 employees in Oregon and 443 in the Eugene-Springfield area at Pinnacle will become Avalon employees when the transfer the lease agreements is completed early next year, bringing the new total of Avalon centers to 49 across Oregon, Arizona, California, Hawaii, Idaho, Utah and Washington. With a total of 8,200 employees, Avalon also has 5,532 beds across all the centers.

“The residents and patients will continue to receive the great care they’ve been receiving from Pinnacle,” he said. “Things will be very much the same day to day.”

 

 

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death
FDA issues Class I recall on insertion tubes after manufacturing error

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.